Targeted Prostate Cancer Screening Programme - MRI Reporting Service

O que a entidade adjudicante procura

The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.<br/><br/>NHS England is seeking a provider to deliver a national centralised Prostate MRI Reporting Service to support the Targeted Prostate Cancer Screening Programme for England.<br/><br/>The service will provide specialist reporting of prostate MRI examinations for Programme Participants requiring MRI following an above-threshold PSA result. The scope will include image receipt or access, case acceptance, specialist human double reporting, lesion delineation where required, expert arbitration, structured report production and authorisation, secure report return, acknowledgement and Failsafe arrangements, quality assurance, escalation, Programme data reporting, audit and governance participation.<br/><br/>Diagnostic MRI scanning is outside the scope of this procurement. The procurement also excludes PSA testing, biopsy delivery, urology treatment, BRCA digital decision-resource development, BRCA genetic testing and development of the national Programme IT system.

Idioma deste anúncio: English. O título e a descrição são apresentados tal como a entidade adjudicante os publicou.